肝移植术后早期高BNP的研究进展  

Research Progress of High BNP in the Early Period after Liver Transplantation

作　　者：王柯宇 刘连腾 李一龙 丁庆宝 李自强 

机构地区：[1]山东第一医科大学,研究生部,山东 济南 [2]山东第一医科大学第一附属医院,肝移植肝脏外科,山东 济南

出　　处：《临床医学进展》2024年第6期205-212,共8页Advances in Clinical Medicine

摘　　要：肝移植已成为终末期肝病最有效治疗方式。但由于手术本身的特点、术前患者的基础状况较差且肝功能失代偿时间长容易造成术后易并发心血管系统的并发症并影响全身各器官功能进而影响预后。B型利钠肽(BNP)是心力衰竭的诊断标志物,术后早期BNP的升高可能会带来受者的急性心力衰竭。本文就肝移植术后早期BNP增加的危险因素及临床意义、肝移植受者心脏风险的预测及围术期管理进行综述。Liver transplantation has become the most effective treatment for end-stage liver disease. However, due to the characteristics of the operation itself, the poor basic condition of the patients before operation and the long time of liver decompensation, it is easy to cause postoperative cardiovascular complications and affect the function of organs in the whole body, thus affecting the prognosis. B-type natriuretic peptide (BNP) is a diagnostic marker of heart failure, and the elevation of BNP in the early postoperative period may bring about acute heart failure in the recipient. This article reviews the risk factors and clinical significance of increased BNP in the early period after liver transplantation, and the prediction and perioperative management of cardiac risk in liver transplantation recipients.

关 键 词：肝移植 BNP 终末期肝病 急性心功能衰竭 

分 类 号：R54[医药卫生—心血管疾病]